Trial intelligence / Profile preview

NOVEL: Nitroglycerin for Postmenopausal Bone Loss

NCT00043719Phase 3Completed

Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Start
Jul 2002
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nitroglycerin in osteopenia, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Jul 2002; status: completed.

02

Drugs

nitroglycerin
03

Conditions

osteopenia

Beyond the preview

Go deeper on NCT00043719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00043719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call